Cary Street Partners Investment Advisory’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,530	Closed	-$434K	–	356
2020 Q3	$434K	Buy	+10,530	New	+$434K	0.09%	189